Tran Capital Management’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,401
Closed -$555K 43
2022
Q4
$555K Hold
28,401
0.07% 32
2022
Q3
$594K Hold
28,401
0.08% 31
2022
Q2
$910K Hold
28,401
0.1% 33
2022
Q1
$1.16M Sell
28,401
-380
-1% -$15.9K 0.1% 38
2021
Q4
$1.28M Sell
28,781
-640
-2% -$30.8K 0.1% 37
2021
Q3
$1.47M Buy
29,421
+387
+1% +$20.2K 0.12% 34
2021
Q2
$1.56M Buy
29,034
+175
+0.6% +$8.79K 0.13% 31
2021
Q1
$1.32M Sell
28,859
-1,670
-5% -$80.2K 0.12% 32
2020
Q4
$1.49M Buy
30,529
+573
+2% +$27.4K 0.14% 36
2020
Q3
$1.33M Sell
29,956
-1,618
-5% -$68.3K 0.14% 44
2020
Q2
$1.21M Sell
31,574
-421
-1% -$17K 0.14% 48
2020
Q1
$1.32M Buy
+31,995
New +$1.53M 0.19% 49

Tran Capital Management's ELAT Position: Q1 2023 in Review

Tran Capital Management sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 28,401 shares — an estimated $555K sold.

Tran Capital Management first reported a position in ELAT in Q1 2020 and held it in 12 quarters. The position peaked at $1.56M in Q2 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • Tran Capital Management reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • Tran Capital Management sold 28,401 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $555K.
  • Tran Capital Management first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 12 quarters.
  • Tran Capital Management's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $1.56M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Tran Capital Management's 13F filing for Q1 2023, filed 18 Apr 2023.